✦ LIBER ✦

Clinical Characteristics Provide Clues to Colorectal Cancer Pathways: Is a KRAS or BRAF Mutation in Control?

✍ Scribed by K.L. DeJulius; J.A. Sanchez; J.M. Church; M.F. Kalady

Book ID: 116707386
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 49 KB
Volume: 165
Category: Article
ISSN: 0022-4804
DOI: 10.1016/j.jss.2010.11.778

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

KRAS or BRAF mutation status is a useful

KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer

✍ Nakayama, N; Nakayama, K; Yeasmin, S; Ishibashi, M; Katagiri, A; Iida, K; Fukumo 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 270 KB

Impact of KRAS and BRAF Gene Mutation St

Impact of KRAS and BRAF Gene Mutation Status on Outcomes From the Phase III AGITG MAX Trial of Capecitabine Alone or in Combination With Bevacizumab and Mitomycin in Advanced Colorectal Cancer

✍ Price, T. J.; Hardingham, J. E.; Lee, C. K.; Weickhardt, A.; Townsend, A. R.; Wr 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 273 KB